These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epigenetics of the Synapse in Neurodegeneration. Xylaki M; Atzler B; Outeiro TF Curr Neurol Neurosci Rep; 2019 Aug; 19(10):72. PubMed ID: 31440934 [TBL] [Abstract][Full Text] [Related]
3. Targeting synapse function and loss for treatment of neurodegenerative diseases. Dejanovic B; Sheng M; Hanson JE Nat Rev Drug Discov; 2024 Jan; 23(1):23-42. PubMed ID: 38012296 [TBL] [Abstract][Full Text] [Related]
4. Uses for humanised mouse models in precision medicine for neurodegenerative disease. Nair RR; Corrochano S; Gasco S; Tibbit C; Thompson D; Maduro C; Ali Z; Fratta P; Arozena AA; Cunningham TJ; Fisher EMC Mamm Genome; 2019 Aug; 30(7-8):173-191. PubMed ID: 31203387 [TBL] [Abstract][Full Text] [Related]
6. Neurodegenerative disease: models, mechanisms, and a new hope. Gitler AD; Dhillon P; Shorter J Dis Model Mech; 2017 May; 10(5):499-502. PubMed ID: 28468935 [TBL] [Abstract][Full Text] [Related]
7. Setting the stage for a role of the postsynaptic proteome in inherited neurometabolic disorders. Bayés À J Inherit Metab Dis; 2018 Nov; 41(6):1093-1101. PubMed ID: 30132229 [TBL] [Abstract][Full Text] [Related]
8. Neurodegenerative Disease: From Molecular Basis to Therapy. Ricci C Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256040 [TBL] [Abstract][Full Text] [Related]
10. The intersection of amyloid beta and tau at synapses in Alzheimer's disease. Spires-Jones TL; Hyman BT Neuron; 2014 May; 82(4):756-71. PubMed ID: 24853936 [TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches. Kubat GB; Picone P Neurol Sci; 2024 Apr; ():. PubMed ID: 38676818 [TBL] [Abstract][Full Text] [Related]
13. Developmental outcomes with perinatal exposure (DOPE) to prescription opioids. Flores A; Nguyen NM; Pendyala G NeuroImmune Pharm Ther; 2023 Dec; 2(4):339-351. PubMed ID: 38058996 [TBL] [Abstract][Full Text] [Related]
14. The dual-path hypothesis for the emergence of anosognosia in Alzheimer's disease. Andrade K; Guieysse T; Medani T; Koechlin E; Pantazis D; Dubois B Front Neurol; 2023; 14():1239057. PubMed ID: 38020610 [TBL] [Abstract][Full Text] [Related]
15. Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration. Albert-Gasco H; Smith HL; Alvarez-Castelao B; Swinden D; Halliday M; Janaki-Raman S; Butcher AJ; Mallucci GR Brain; 2024 Feb; 147(2):649-664. PubMed ID: 37703312 [TBL] [Abstract][Full Text] [Related]
16. Axonal energy metabolism, and the effects in aging and neurodegenerative diseases. Yang S; Park JH; Lu HC Mol Neurodegener; 2023 Jul; 18(1):49. PubMed ID: 37475056 [TBL] [Abstract][Full Text] [Related]
17. Aggregation-prone Tau impairs mitochondrial import, which affects organelle morphology and neuronal complexity. Needs HI; Wilkinson KA; Henley JM; Collinson I J Cell Sci; 2023 Jul; 136(13):. PubMed ID: 37303235 [TBL] [Abstract][Full Text] [Related]